T. Rowe Price Investment Management
MRK icon

T. Rowe Price Investment Management’s Merck MRK Stock Holding History

T. Rowe Price Investment Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$995K Buy
+8,270
New +$955K ﹤0.01% 623

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Investment Management's MRK Position: Q1 2026 in Review

T. Rowe Price Investment Management opened a new position in Merck (MRK) in Q1 2026: 8,270 shares worth $995K. The stake represents ﹤0.01% of the portfolio and ranks #623 among its holdings.

3,789 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • T. Rowe Price Investment Management held 8,270 shares of Merck worth $995K as of Q1 2026.
  • Merck was a new T. Rowe Price Investment Management position in Q1 2026.
  • Merck made up ﹤0.01% of T. Rowe Price Investment Management's portfolio in Q1 2026, its #623 holding.
  • 3,789 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on T. Rowe Price Investment Management's 13F filing for Q1 2026, filed 15 May 2026.